Valentina Guarneri - Department of Surgery, Oncology and Gastroenterology, University of Padua

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

HER2DX genomic assay in advanced HER2-positive (HER2+) breast cancer treated with T-DM1

F. Braso-Maristany, G. Griguolo,N. Chic,L. Pare Brunet, P. Galvan,M. V. Dieci, F. Miglietta, T. Giarratano, O. Martinez-Saez,M. Marin,M. J. Vidal Losada, B. Adamo,

Annals of Oncology（2022）

引用1浏览0引用

Prognostic factors associated with clinical outcomes in HR+, HER2-Advanced Breast Cancer (ABC) - Systematic Literature Review (SLR)

S. Kuemmel,Cuyun G. Carter, K. Stenger,M. Mohanty, A. L. Chong, P. Basa, S. Singuru,S. Singh,V Tongbram,V Guarneri,S. M. Tolaney

ONCOLOGY RESEARCH AND TREATMENT（2020）

引用0浏览0引用

95TiP Gruppo Italiano Mammella (GIM) 10–CONSENT: A phase III randomized study comparing concurrent versus sequential administration of adjuvant chemotherapy (CT) and aromatase …

M Lambertini,V Guarneri,ER Caremoli,A Rocca,F Montemurro,M De Laurentiis,M Giordano,S De Placido,G Bisagni,O Garrone, A Ferzi,F Giovanardi,

Annals of Oncology（2020）

引用0浏览0引用

Abstract P2-08-06: Standardized nCounter-based determination of estrogen receptor (ER), progesterone receptor (PR) and HER2 receptor status in breast cancer

T Pascual, Ys Tsai,M Martín,A Lluch,J Cortes,A Llombart, P Conte,V Guarneri,Mf Rimawi,E Alba,M Ruiz-Borrego,F Rojo,

CANCER RESEARCH（2019）

引用0浏览0引用

Carboplatin-containing neoadjuvant chemotherapy for triple negative breast cancer (TNBC): A propensity score-matched study

M.V. Dieci, C.A. Giorgi,G. Griguolo, S. Angelini,F. Miglietta, T. Giarratano, C. Falci, G. Faggioni, G. Tasca, E. Mioranza,G. Vernaci, A. Menichetti,

ANNALS OF ONCOLOGY（2019）

引用0浏览0引用

20PERBB2 mRNA as predictor of response to anti-HER2 antibody-drug conjugates (ADC) in breast cancer (BC)

G Griguolo, F Brasó-Maristany,T Pascual,N Chic,M Vidal,B Adamo, T Giarratano,M V Dieci,V Guarneri,A Prat

Annals of Oncology（2019）

引用4浏览0WOS引用

Abstract PD5-01: Final results of NeoMONARCH: A phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC)

M. Martin, S. Hurvitz,D. Chan,M Fernandez-Abad, E Petru, R. Rostorfer,V Guarneri, C-S Huang,Mf Press, Tm Costigan,Cw Caldwell, S Wijayawardana,

Cancer Research（2018）

引用21浏览0引用

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2-breast cancer

P. A. Fasching,M. Fernandez Abad, J. A. Garcia-Saenz,A. Schneeweiss,V. Guarneri,M. Colleoni,E. Petru,T. M. Costigan,C. W. Caldwell,S. Barriga, S. Hurvitz,D. Slamon

ANNALS OF ONCOLOGY（2017）

引用2浏览0引用

C3Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer

V Guarneri,P A Fasching,M Fernández Abad, J A García-Saenz,A Schneeweiss,M Colleoni,E Petru,Tm Costigan,Cw Caldwell,S Barriga, S Hurvitz,D Slamon

Annals of Oncology（2017）

引用1浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn